Evidence map›Paper›PMID 42788456›Full record

ArticleInternational journal of preventive medicine2026

Designing the Data Elements for Patient Registry System for Membranous Nephropathy in Isfahan Province.

Firouzeh Moeinzadeh, Seyed Hamidreza Motafakeran, Mojgan Mortazavi, Shahrzad Shahidi, Golsa Ghasemi

Abstract read
In one paragraph

Article in International journal of preventive medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Firouzeh MoeinzadehIsfahan Kidney Diseases Research Center, Al-Zahra Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
Seyed Hamidreza MotafakeranIsfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Mojgan MortazaviIsfahan Kidney Diseases Research Center, Al-Zahra Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
Shahrzad ShahidiIsfahan Kidney Diseases Research Center, Khorshid Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
Golsa GhasemiIsfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Membranous nephropathy is one of the most common glomerulonephritis types in adults. Various treatment methods are applied for this disease. Establishing a patient registry system and analyzing the collected data can help identify the strengths and limitations of current treatment approaches. This enables the adoption of more effective therapies, preventing disease progression to end-stage renal disease. Furthermore, consolidating patient information into a unified electronic system has diverse applications. Methods: This action research study utilized patient medical records (including hospital files, clinic cards, test reports, and prescriptions) as the primary data sources. In cases of incomplete information, data were collected from patients or their close relatives. Patient information was gathered using a checklist. Data analysis employed tests as necessary, depending on the objectives. Results: The final version of the checklist consisted of three sections: demographic variables (age, gender, education level, residence, date of birth, occupation, and contact information), laboratory tests, pharmaceutical variables, and treatment protocols used for patients. This information was systematically collected for all patients. Conclusions: Establishing a registry for membranous nephropathy in Isfahan is critical in improving treatment and control of this disease within the Iranian population. Comparing this data with similar studies from other regions can reveal epidemiological and clinical differences, which can be leveraged to enhance diagnostic and therapeutic strategies.

Indexed as

Glomerulonephritismembranous nephropathypatient registry system

Identifiers

PMID42788456
PMCPMC13570685

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.